Roche Submits Filing To FDA For Cervical Cancer Primary Screening Indication … – Daily Markets

Roche Submits Filing To FDA For Cervical Cancer Primary Screening Indication
Daily Markets
The cobasĀ® HPV Test is the only FDA approved test that provides pooled results for known high risk genotypes and in addition, simultaneously provides individual results for the 2 highest risk genotypes, HPV 16 and HPV 18. Data from the ATHENA study 

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *